2021年9月至2022年12月美国18个司法管辖区≥18岁成人中实验室确诊SARS-CoV-2再感染及相关住院和死亡趋势
分析美国18个司法管辖区2021年9月5日至2022年12月31日每周报告的SARS-CoV-2再感染、总感染及相关住院和死亡数据。再感染占所有感染的比例从Delta期的2.7%升至Omicron BQ.1/BQ.1.1期的28.8%,再感染占COVID-19相关住院比例从1.9%升至17.0%,占死亡比例从1.2%升至12.3%。18-49岁成人再感染占比在各变异株期均高于≥50岁成人。CDC推荐及时接种COVID-19疫苗并在符合条件时接受抗病毒治疗。
要点
- 再感染占所有感染比例从Delta期2.7%升至Omicron BQ.1/BQ.1.1期28.8%。
- 再感染占COVID-19住院比例从Delta期1.9%升至Omicron BQ.1/BQ.1.1期17.0%。
- 再感染占COVID-19死亡比例从Delta期1.2%升至Omicron BQ.1/BQ.1.1期12.3%。
核心结论
- 再感染占所有感染、COVID-19相关住院和死亡的比例从Delta期至Omicron BQ.1/BQ.1.1期大幅上升。
- 18-49岁成人再感染占所有COVID-19病例、住院和死亡的比例在各变异株期均高于≥50岁成人。
研究设计与样本
- 分析美国18个司法管辖区2021年9月5日至2022年12月31日每周报告的SARS-CoV-2再感染、总感染及相关住院和死亡数据。
- 按年龄组和五个SARS-CoV-2变异株优势期(Delta及Omicron BA.1、BA.2、BA.4/BA.5、BQ.1/BQ.1.1)分析。
- 计算再感染病例中感染间期中位数及既往感染优势变异株频率的每周趋势。
主要发现
- 再感染占所有感染比例从Delta期2.7%升至Omicron BQ.1/BQ.1.1期28.8%。
- 再感染占COVID-19相关住院比例从Delta期1.9%升至Omicron BQ.1/BQ.1.1期17.0%。
- 再感染占COVID-19相关死亡比例从Delta期1.2%升至Omicron BQ.1/BQ.1.1期12.3%。
- 感染间期中位数按周范围为269至411天,在BA.4/BA.5期开始时急剧下降,当时>50%的再感染发生在Alpha变异株期或之后感染的人群中。
临床怎么用
- CDC推荐保持COVID-19疫苗接种最新状态,并在符合条件时及时接受抗病毒治疗,以预防包括再感染后在内的重症COVID-19结局。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although reinfections with SARS-CoV-2 have occurred in the United States with increasing frequency, U.S. epidemiologic trends in reinfections and associated severe outcomes have not been characterized. Weekly counts of SARS-CoV-2 reinfections, total infections, and associated hospitalizations and deaths reported by 18 U.S. jurisdictions during September 5, 2021-December 31, 2022, were analyzed overall, by age group, and by five periods of SARS-CoV-2 variant predominance (Delta and Omicron [BA.1, BA.2, BA.4/BA.5, and BQ.1/BQ.1.1]). Among reported reinfections, weekly trends in the median intervals between infections and frequencies of predominant variants during previous infections were calculated. As a percentage of all infections, reinfections increased substantially from the Delta (2.7%) to the Omicron BQ.1/BQ.1.1 (28.8%) periods; during the same periods, increases in the percentages of reinfections among COVID-19-associated hospitalizations (from 1.9% [Delta] to 17.0% [Omicron BQ.1/BQ.1.1]) and deaths (from 1.2% [Delta] to 12.3% [Omicron BQ.1/BQ.1.1]) were also substantial. Percentages of all COVID-19 cases, hospitalizations, and deaths that were reinfections were consistently higher across variant periods among adults aged 18-49 years compared with those among adults aged ≥50 years. The median interval between infections ranged from 269 to 411 days by week, with a steep decline at the start of the BA.4/BA.5 period, when >50% of reinfections occurred among persons previously infected during the Alpha variant period or later. To prevent severe COVID-19 outcomes, including those following reinfection, CDC recommends staying up to date with COVID-19 vaccination and receiving timely antiviral treatments, when eligible.
引用
- Ma KC, Dorabawila V, León TM, et al. Trends in Laboratory-Confirmed SARS-CoV-2 Reinfections and Associated Hospitalizations and Deaths Among Adults Aged ≥18 Years - 18 U.S. Jurisdictions, September 2021-December 2022. MMWR Morb Mortal Wkly Rep. 2023. PMID: 37347715. doi:10.15585/mmwr.mm7225a3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。